A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases Journal Article


Authors: Richon, V. M.; Emiliani, S.; Verdin, E.; Webb, Y.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
Article Title: A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Abstract: Hybrid polar compounds (HPCs) have been synthesized that induce terminal differentiation and/or apoptosis in various transformed cells. We have previously reported on the development of the second-generation HPCs suberoylanilide hydroxamic acid (SAHA) and m-carboxycinnamic acid bishydroxamide (CBHA) that are 2,000-fold more potent inducers on a molar basis than the prototype HPC hexamethylene bisacetamide (HMBA). Herein we report that CBHA and SAHA inhibit histone deacetylase 1 (HDAC1) and histone deacetylase 3 (HDAC3) activity in vitro. Treatment of cells in culture with SAHA results in a marked hyperacetylation of histone H4, but culture with HMBA does not. Murine erythroleukemia cells developed for resistance to SAHA are cross-resistant to trichostatin A, a known deacetylase inhibitor and differentiation inducer, but are not cross-resistant to HMBA. These studies show that the second-generation HPCs, unlike HMBA, are potent inhibitors of HDAC activity. In this sense, HMBA and the second-generation HPCs appear to induce differentiation by different pathways.
Keywords: unclassified drug; human cell; histone deacetylase inhibitor; nonhuman; animal cell; mouse; animals; mice; enzyme inhibition; cell differentiation; drug resistance; enzyme inhibitor; drug synthesis; urinary bladder neoplasms; animalia; cell transformation, neoplastic; cancer inhibition; cell transformation; carcinoma; immunoprecipitation; murinae; vorinostat; hydroxamic acids; cell line, transformed; histones; histone deacetylases; histone deacetylase; leukemia cell line; trichostatin a; acetylation; cinnamates; leukemia, erythroblastic, acute; hexamethylenebisacetamide; acetamides; humans; human; priority journal; article; 3 carboxycinnamic acid bishydroxamide; erythroleukemia cell; malonates
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 95
Issue: 6
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 1998-03-17
Start Page: 3003
End Page: 3007
Language: English
DOI: 10.1073/pnas.95.6.3003
PUBMED: 9501205
PROVIDER: scopus
PMCID: PMC19684
DOI/URL:
Notes: Article -- Export Date: 12 December 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Victoria M Richon
    91 Richon
  2. Paul Marks
    186 Marks
  3. Richard Rifkind
    118 Rifkind